Related Experiment Videos
Infantile polymyositis: a case report
1Department of Neurology, Tokyo Metropolitan Kiyose Children's Hospital, Japan.
Insights
Infantile polymyositis in a Japanese boy showed little response to steroid and immunosuppressive treatments. Despite normalized serum creatine kinase (CK) levels, muscle weakness persisted, contrasting with prior research.
Area of Science:
- Pediatric Neurology
- Inflammatory Myopathies
- Clinical Case Study
Background:
- Infantile polymyositis is a rare inflammatory myopathy characterized by muscle weakness and elevated creatine kinase (CK).
- Treatment typically involves corticosteroids and immunosuppressive agents, often leading to significant clinical improvement.
Observation:
- A 10-month-old Japanese boy presented with progressive muscle weakness and hypotonia from 3 months of age.
- Muscle biopsy revealed significant inflammatory cellular infiltration, leading to a diagnosis of infantile polymyositis.
- The patient was treated with steroid and immunosuppressive medication at 10 months of age.
Findings:
- The patient's physical condition showed no significant alteration despite treatment.
- Serum creatine kinase (CK) levels normalized from 1,500 iu/l to 90 iu/l.
- This lack of clinical improvement contrasts with previously reported cases responding well to steroid administration.
Implications:
- This case highlights potential variability in treatment response for infantile polymyositis.
- It suggests that normalization of serum CK levels may not always correlate with clinical recovery in this condition.
- Further research is needed to understand factors influencing treatment efficacy in pediatric inflammatory myopathies.
Abstract:
A 10-month-old Japanese boy developed progressive muscle weakness and hypotonia at 3 months of age. Because of striking inflammatory cellular infiltration in his muscle biopsy, he was diagnosed as having infantile polymyositis and was placed on steroid and immunosuppressive medication when he was 10-month-old. His physical condition was not significantly altered, though serum creatine kinase (CK) level was normalized (1,500 iu/l----90 iu/l). These findings contrast with previous reports documenting improvement with steroid administration.